HPN and prostate carcinoma: Treatment of LPB-Tag/PB-Hepsin mice with Hepsin inhibitor HepIn-13 completely suppressed the development of bone metastasis, strongly suggesting that Hepsin plays an important role in the skeletal spread of prostate cancer.